Author

F Roubille

Institutions: Centre National de la Recherche Scientifique, Inserm, Université de Montpellier, Physiologie et Médecine Expérimentale du Coeur et des Muscles, Centre Hospitalier Universitaire de Montpellier, Hôpital Arnaud de Villeneuve

Observed institutions: Centre National de la Recherche Scientifique, Inserm, Université de Montpellier, Physiologie et Médecine Expérimentale du Coeur et des Muscles, Centre Hospitalier Universitaire de Montpellier, Hôpital Arnaud de Villeneuve

OpenAlex ID: A5159513748

Sex differences in cardiovascular inflammation defined by high-sensitivity C-reactive protein across heart failure phenotypes: insights from POSEIDON

2026 · S Stoerk, W P Abhayaratna, et al. · European Heart Journal

Real-world clinical characterisation and comorbidity burden of heart failure patients in a national remote monitoring program: the CODEC-HF registry

2026 · E Berthelot, G Faedda, et al. · European Heart Journal

Age-dependent sex differences and tafamidis treatment-associated outcomes in transthyretin wild-type cardiac amyloidosis: a nationwide multicenter study

2026 · A Zaroui, C Dagrenat, et al. · European Heart Journal

Catheter-directed therapy in intermediate-high risk pulmonary embolism: which predictive factors for a favorable therapy response?

2026 · E Blachere, P Segui, et al. · European Heart Journal

Sevenfold inter-center variation in female representation and its association with myocardial severity in ATTR-CM: data from the nationwide HEAR Registry

2026 · A Zaroui, C A Charlotte Dagrenat, et al. · European Heart Journal

Prevalence of high inflammatory risk (hsCRP ≥2 mg/L) in European patients with atherosclerotic cardiovascular disease with/without chronic kidney disease: sub-analysis of the global POSEIDON study

2026 · D Leistner, M Bottcher, et al. · European Heart Journal

Works count: 6

Citation count:

H-index:

I10-index: